Home | Medical-Newswire.Com:
(Medical-NewsWire.com, June 17, 2017 ) The report "Fertility Testing Devices Market Product (Ovulation Prediction Kit & Fertility Monitor (Urine-based, Saliva-based, & Basal Body Temperature)), Mode of Purchase (Prescription & OTC), and Region - Global Forecast to 2020"The global fertility testing devices market was estimated at USD 151.0 Million in 2015; it is poised to grow at a CAGR of 7.5% during the forecast period to reach USD 216.8 Million by 2020.
Browse 47 market data Tables and 35 Figures spread through 122 Pages and in-depth TOC on "Fertility Testing Devices Market “ <||>rnhttp://www.marketsandmarkets.com/Market-Reports/fertility-testing-devices-market-139945432.html
Early buyers will receive 10% customization on this report.
The emergence of advanced and easy-to-use ovulation monitors with high accuracy, rising median age of first-time pregnancies in women, and increasing awareness about fertility testing are driving the growth of the market. In addition, factors such as declining fertility rate among women across the globe and easy availability of ovulation monitors on e-commerce websites are further stimulating the growth of the market. However, the increasing inflow of generic fertility testing devices, high cost of ovulation monitors, and lack of predictive power & precision in modern ovulation prediction methods (to confirm ovulation) are restraining the growth of the market.
Get The PDF Brochure For This Report@ <||>rnhttp://www.marketsandmarkets.com/pdfdownload.asp?id=139945432
The global fertility testing devices market is broadly categorized into two segments, namely, ovulation prediction kits and fertility monitors. The ovulation prediction kits segment accounts for the larger share of the global market, while the fertility monitors segment is expected to grow at the higher CAGR in the forecast period. The high growth of this segment is driven by the high accuracy of fertility monitors, especially in women suffering from PCOS, and increase in the number of product launches of advanced fertility monitors. The fertility monitors segment includes saliva-based monitors, urine-based monitors, and others.
Based on the type of mode of purchase, the global fertility testing devices market is divided into two segments prescription-based and non-prescription or OTC (over-the-counter) based. The non-prescription or OTC-based segment commanded the larger share of the global market. The large share of this segment is attributed to the increasing initiatives taken by market players to spread awareness on fertility, easy availability of fertility and ovulation monitors on e-commerce websites, rising preference for confidentiality and accessibility of test results, and rapid outcomes of diagnosis.
Download Sample Pages of this Report@ <||>rnhttp://www.marketsandmarkets.com/requestsample.asp?id=139945432
Based on geography, the market is divided into North America (comprising the U.S. and Canada), Europe (comprising Germany, U.K., France, and the Rest of Europe), Asia-Pacific, and the Rest of the World. In 2015, North America held the largest share in the global fertility testing devices market, followed by Europe, Asia-Pacific, and the RoW (Rest of the World). The Asia-Pacific region is estimated to grow at the highest CAGR in the forecast period. Factors such as decreasing fertility rate, growing number of women suffering from lifestyle disorders, rising funding/investments for the development of fertility and ovulation monitors, and growing focus of both international and domestic players on the Asia-Pacific market are driving the growth of the fertility testing devices market in the Asia-Pacific region.
The key players in the fertility testing devices market include SPD Swiss Precision Diagnostics GmbH (Switzerland), Church & Dwight Co., Inc. (U.S.), Prestige Brands Holdings, Inc. (U.S.), Fairhaven Health, LLC (U.S.), HiLin Life Products, Inc. (U.S.), Fertility Focus Limited (U.K.), and Geratherm Medical AG (Germany).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States